Additional file 1 of Projections of disability-adjusted life years for major diseases due to a change in vegetable intake in 2017–2040 in Japan
Creators: name: Tanaka, Shiori
name: Yoneoka, Daisuke
name: Ishizuka, Aya
name: Ueda, Peter
name: Nakamura, Keiji
name: Uneyama, Hisayuki
name: Hayashi, Naoki
name: Shibuya, Kenji
name: Nomura, Shuhei
Publisher: name: figshare
Year: 2021
Subjects: subject: Medicine
subject: 69999 Biological Sciences not elsewhere classified
subject: FOS: Biological sciences
subject: FOS: Biological sciences
subject: Inorganic Chemistry
subject: FOS: Chemical sciences
subject: FOS: Chemical sciences
subject: Science Policy

description: Additional file 1: Figure S1. Observed and projected DALY rate (per 100,000 population) in the 20–49 age group for cardiovascular diseases for reference forecast and three alternative scenarios, 1990–2040: (A) male, (B) female, and (C) total population. The black lines represent the observed values, and the pink lines and the grey areas before 2016 represent the smoothed lines and their projection intervals. Figure S2. Observed and projected DALY rates (per 100,000 population) in the 50–69 age group for cardiovascular diseases for reference forecast and three alternative scenarios, 1990–2040: (A) male, (B) female, and (C) total population. The black lines represent the observed values, and the pink lines and the grey areas before 2016 represent the smoothed lines and their projection intervals. Figure S3. Observed and projected DALY rates (per 100,000 population) in the ≥70 age group for cardiovascular diseases for reference forecast and three alternative scenarios, 1990–2040: (A) male, (B) female, and (C) total population. The black lines represent the observed values, and the pink lines and the grey areas before 2016 represent the smoothed lines and their projection intervals. Figure S4. Observed and projected DALY rates (per 100,000 population) for cancer in the 20–49 age group for reference forecast and three alternative scenarios, 1990–2040: (A) male, (B) female, and (C) total population. The black lines represent the observed values, and the pink lines and the grey areas before 2016 represent the smoothed lines and their projection intervals. Figure S5. Observed and projected DALY rates (per 100,000 population) in the 50–69 age group for cancer for reference forecast and three alternative scenarios, 1990–2040: (A) male, (B) female, and (C) total population. The black lines represent the observed values, and the pink lines and the grey areas before 2016 represent the smoothed lines and their projection intervals. Figure S6. Observed and projected DALY rates (per 100,000 population) in the ≥70 age group for cancer for reference forecast and three alternative scenarios, 1990–2040: (A) male, (B) female, and (C) total population. The black lines represent the observed values, and the pink lines and the grey areas before 2016 represent the smoothed lines and their projection intervals. Figure S7. Observed and projected DALY rates (per 100,000 population) in the 20–49 age group for diabetes and kidney diseases for reference forecast and three alternative scenarios, 1990–2040: (A) male, (B) female, and (C) total population. The black lines represent the observed values, and the pink lines and the grey areas before 2016 represent the smoothed lines and their projection intervals. Figure S8. Observed and projected DALY rates (per 100,000 population) in the 50–69 age group for diabetes and kidney diseases for reference forecast and three alternative scenarios, 1990–2040: (A) male, (B) female, and (C) total population. The black lines represent the observed values, and the pink lines and the grey areas before 2016 represent the smoothed lines and their projection intervals. Figure S9. Observed and projected DALY rates (per 100,000 population) in the ≥70 age group for diabetes and kidney diseases for reference forecast and three alternative scenarios, 1990–2040: (A) male, (B) female, and (C) total population. The black lines represent the observed values, and the pink lines and the grey areas before 2016 represent the smoothed lines and their projection intervals. Table S1. Estimated sets of parameters in ARIMA (p, d, q) and Akaike Information Criteria (AIC). Table S2. Predicted DALY rates (95% prediction intervals) for cardiovascular disease by age groups, sex (male, female), and total population, 2017–2040. Table S3. Predicted DALY rates (95% prediction intervals) for cancer by age groups, sex (male, female), and total population, 2017–2040. Table S4. Predicted DALY rates (95% prediction intervals) for diabetes and kidney diseases by age groups, sex (male, female), and total population, 2017–2040.